21 CFR 26.3 - Scope.
(a) The provisions of this subpart shall apply to pharmaceutical inspections carried out in the United States and Member States of the European Community (EC) before products are marketed (hereafter referred to as “preapproval inspections”) as well as during their marketing (hereafter referred to as “postapproval inspections”).
(c) Appendix B of this subpart lists the authorities participating in activities under this subpart.
Title 21 published on 2015-12-03.
No entries appear in the Federal Register after this date, for 21 CFR Part 26.